Variant requirements for DNA repair proteins in cancer cell lines that use alternative lengthening of telomere mechanisms of elongation
DISSERTATION
Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University
By
Alaina Rae Martinez
Biomedical Sciences Graduate Program
The Ohio State University
2016
Dissertation Committee:
Dr. Jeffrey D. Parvin, Advisor
Dr. Joanna Groden Dr. Amanda E. Toland Dr. Kay F. Huebner
Copyright by
Alaina Rae Martinez
2016
Abstract
The human genome relies on DNA repair proteins and the telomere to maintain genome stability. Genome instability is recognized as a hallmark of cancer, as is limitless replicative capacity. Cancer cells require telomere maintenance to enable this uncontrolled growth. Most often telomerase is activated, although a subset of human cancers depend on recombination-based mechanisms known as Alternative Lengthening of Telomeres (ALT). ALT depends invariably on recombination and its associated DNA repair proteins to extend telomeres. This study tested the hypothesis that the requirement for those requisite recombination proteins include other types of DNA repair proteins. These functions were tested in ALT cell lines using C-circle abundance as a marker of ALT. The requirement for homologous recombination proteins and other DNA repair proteins varied between ALT cell lines compared. Several proteins essential for homologous recombination were dispensable for C-circle production in some ALT cell lines, while proteins grouped into excision DNA repair processes were required for C- circle production. The MSH2 mismatch repair protein was required for telomere recombination by intertelomeric exchange. In sum, our study suggests that ALT proceeds by multiple mechanisms that differ between human cancer cell lines and that some of these depend on DNA repair proteins not associated with homologous recombination pathways. Further studies of all DNA repair pathways in ALT will likely lead to a better understanding of ALT mechanisms and ultimately better ALT-targeted therapeutics. ii
Dedication
To my grandparents, parents and husband who have worked hard and made sacrifices so that I could have this opportunity and to my siblings for being examples for me to follow.
iii
Acknowledgments
I would like to acknowledge my advisors Dr. Jeffrey Parvin and Dr. Joanna
Groden for their guidance and encouragement throughout graduate school. I would like to thank committee members Dr. Amanda Toland and Dr. Kay Huebner for their helpful suggestions, interest in my project and thought-provoking questions. I would like to thank the 9th floor of the BRT; they have been a very collegial and friendly group of cancer researchers. Over the years there have been many members of the Parvin and Groden labs and rotation labs that I have been lucky to have met. Many became not only friends but
my “Columbus family” who supported me through the hard times. I am so grateful for
those friendships and could not have made it through graduate school without them.
I would also like to thank those who have guided me to this point in my life: teachers from Lewiston-Porter; professors from The College of Wooster, who believed in my capabilities; Dr. José Lemos who provided me the same opportunities, as a lab technician, as he did his students and prepared me for grad school; to him, Dr. Jacqueline Abranches and Dr. Jessica Kajfasz, who sparked my interest in pursuing a PhD; Lemos lab friends that lent empathetic ears and encouraged me. I thank my family and friends for support, love and belief in me. Lastly, I would like to thank my husband, Senyo. It was difficult to be away from each other for five years but he encouraged me to finish graduate school. I look forward to spending the rest of my life with him, finally!
iv
Vita
May 2007 .......................................................B.A. Biochemistry & Molecular Biology,
The College of Wooster
2010 to present ..............................................PhD Candidate, The Ohio State University
Publications
Acharya, S., Kaul, Z., Gocha, A.S., Martinez, A.R., Harris, J., Parvin, J.D., and Groden,
J. (2014). Association of BLM and BRCA1 during telomere maintenance in ALT cells. PLoS One 9: 1–13.
Singh, M., Martinez, A.R., Lee, B.S. (2013). HuR inhibits apoptosis by amplifying Akt signaling through a positive feedback loop. J Cell Physio 228: 182-189.
Abranches, J., Miller, J.H., Martinez, A.R., Simpson-Haidaris, P.J., Burne, R.A., Lemos,
J.A. (2011). The collagen-binding protein Cnm is required for Streptococcus mutans adherence to and intracellular invasion of human coronary artery endothelial cells. Infect and Immun 79: 2277-2284.
Martinez, A.R., Abranches, J., Kajfasz, J.K., Lemos, J.A. (2010). Characterization of the
S. sobrinus acid-stress response by interspecies microarrays and proteomics. Mol Oral Micro 25: 331-342.
Kajfasz, J.K., Rivera-Ramos, I., Abranches, J., Martinez, A.R., Rosalen, P.L., Derr,
A.M., Quivey R.G., Lemos, J.A. (2010). Global regulation by two Spx proteins modulate stress tolerance, survival, and virulence in S. mutans. J Bacteriol 192: 2546-2556.
Abranches, J., Martinez, A.R., Kajfasz, J.K., Chávez, V., Garsin, D.A., Lemos, J.A.
(2009). The molecular alarmone (p)ppGpp mediates stress responses, Vancomycin tolerance, and virulence in Enterococcus faecalis. J Bacteriol 191: 2248-2256.
Kajfasz, J.K., Martinez, A.R., Rivera-Ramos, I., Abranches, J., Koo, H., Quivey, Jr.,
R.G., Lemos, J.A. (2009). Role of Clp proteins in the expression of virulence properties of Streptococcus mutans. J Bacteriol 191: 2060-2068.
Fields of Study
Major Field: Biomedical Sciences v
Table of Contents
Abstract............................................................................................................................... ii Dedication..........................................................................................................................iii Acknowledgments.............................................................................................................. iv Vita...................................................................................................................................... v Publications......................................................................................................................... v List of Tables ..................................................................................................................... ix List of Figures..................................................................................................................... x Chapter 1: Functions of DNA Repair Proteins in Alternative Lengthening of Telomere Mechanisms ........................................................................................................................ 1
I. Telomere maintenance................................................................................................. 2
I.1 Telomere structure and function ............................................................................ 2 I.2 Telomerase ............................................................................................................. 4 I.3 Alternative lengthening of telomeres ..................................................................... 4
II. DNA repair proteins in ALT ...................................................................................... 9
II.1 DNA damage sensors.......................................................................................... 10 II.2 Chromatin modifiers ........................................................................................... 12 vi
II.3 Double-strand break proteins.............................................................................. 13 II.4 RecQ-like helicases............................................................................................. 18 II.5 Excision repair .................................................................................................... 19
Chapter 2: Thesis Rationale and Research Objectives ..................................................... 26 Chapter 3: Differential Requirements for DNA Repair Proteins in Cell Lines Using Alternative Lengthening of Telomere Mechanisms ......................................................... 29
I. Introduction................................................................................................................ 29 II. Materials and methods.............................................................................................. 32
Cell line s.................................................................................................................... 32 siRNA knockdow n...................................................................................................... 32 Western blots ............................................................................................................. 33 qRT PCR assays......................................................................................................... 33 C-circle assays........................................................................................................... 33 Telomere sister chromatid exchange assays ............................................................. 34 Homology-directed repair assays.............................................................................. 35
III. Results..................................................................................................................... 37
BRCA1 depletion in five ALT cell lines decreases C-circles, a quantifiable marker of
ALT ............................................................................................................................ 37 vii
ALT cells do not depend on all requisite homologous recombination proteins for telomere maintenance although requirements differ between ALT-positive cell lines
................................................................................................................................... 42
Non-homologous end joining proteins are not critical for ALT................................ 47 Nucleotide excision repair, DNA mismatch repair, and base excision repair proteins
can contribute to AL T................................................................................................ 47
MSH2 stimulates intertelomeric exchanges in U-2 OS ALT cells and MSH2 and MPG affect homology-directed repair in HeLa cells ................................................ 50
IV. Discussion............................................................................................................... 55
Chapter 4: Thesis Summary and Future Directions.......................................................... 59
I. Thesis summary ........................................................................................................ 59 II. Future directions....................................................................................................... 63 III. Significance of understanding mechanisms of ALT............................................... 75
References......................................................................................................................... 77
viii
List of Tables
Table 1. Sequence of siRNAs and quantitative PCR primers............................................ 36 Table 2. Summary of data from DNA repair depletions and C-circle measurements in ALT cells .......................................................................................................................... 58
ix
List of Figures
Figure 1: T-loop with shelterin complex. ........................................................................... 3 Figure 2: ALT cells have distinct and characteristic cytological phenotypes. ................... 7 Figure 3: C-circle assay (CC assay).................................................................................... 9 Figure 4: DNA damage sensing and recruitment of proteins to a double-strand break.... 11 Figure 5: Homologous recombination DNA repair pathway............................................ 15 Figure 6: Non-homologous end joining DNA repair pathway. ........................................ 17 Figure 7: Nucleotide excision DNA repair pathway......................................................... 21 Figure 8: Mismatch DNA repair pathway. ....................................................................... 23 Figure 9: Base excision DNA repair pathway. ................................................................. 24 Figure 10: Depletion of BRCA1 reduces C-circles in five ALT cell lines but not in a telomerase-dependent cell line.......................................................................................... 39 Figure 11: Knockdown of BRCA1 using a second siRNA reduces C-circles in ALT cell lines and confirms previous experiments.......................................................................... 41 Figure 12: Depletion of homologous recombination proteins BARD1, BRCA2, PALB2 or WRN in ALT cells do not alter C-circle abundance......................................................... 43 Figure 13: Depletion of RNF8 or RNF168 lowers C-circle levels in VA-13 cells and depletion of NHEJ proteins does not alter C-circle abundance in Saos-2, U-2 OS or VA- 13 cells. ............................................................................................................................. 46
x
Figure 14: Depletion of XPA, MSH2 or MPG lowers C-circle levels in U-2 OS and VA- 13 cells. ............................................................................................................................. 49 Figure 15: Depletion of MSH2, XPA or MPG lowers intertelomeric exchanges in U-2 OS cells............................................................................................................................. 52 Figure 16: Depletion of MSH2 (MMR) or MPG (BER) proteins decrease homologydirected repair (HDR). ...................................................................................................... 54 Figure 17: Variant requirements for DNA repair proteins in ALT................................... 62
xi
Chapter 1: Functions of DNA Repair Proteins in Alternative Lengthening of
Telomere Mechanisms
Maintenance of genome integrity is a critical process in human cells as select unrepaired mutations cause genome instability which can precipitate human diseases such as premature aging, chronic pulmonary disease and cancer. Human cells are faced with the challenge of repairing tens of thousands of DNA lesions per day in order to preserve genome integrity. DNA repair relies on concerted functions from a host of proteins: DNA damage sensors, DNA damage signaling and cell cycle checkpoint proteins, mediator proteins, and nucleases, polymerases, helicases and ligases (Jackson and Bartek, 2009). Some of these proteins function not only to protect DNA in the genome but also DNA found at the end of chromosomes that compose the telomere. The telomere is a DNA- protein structure that also functions to maintain genome integrity as it protects genomic DNA from deterioration and prevents DNA ends from eliciting a DNA damage response. DNA repair proteins and the telomere are linked in their ability to maintain genome integrity. In some cancer cell lines and tumor types, DNA repair proteins are required for mechanisms of Alternative Lengthening of Telomeres (ALT). Activation of this telomere lengthening maintenance mechanism(s) in cells permits uncontrolled proliferation, which is necessary for the onset of cancer.
1
I. Telomere maintenance
I.1 Telomere structure and function
Normal human cells have functions and structures that prevent the cell from becoming neoplastic. One key structure is the telomere, in humans, which is a noncoding stretch of DNA made up of 5′TTAGGG3′ and complementary 5′CCCTAA3′ repeats at the end of a chromosome. Telomeres can range from 10-14 kb in length in normal cells and have a 3′ G-rich over-hang of 130-210 base-pairs in length (de Lange et al., 1990; Makarov et al., 1997). The G-rich overhang is sufficient for preventing end-to-end chromosome fusions, but if left in a linear confirmation it would be detected as a doublestrand break (DSB) (Zhu et al., 2003). To prevent this, the telomere forms a “t-loop” in which the 3′ G-rich overhang invades the double strand portion of the telomere forming a D-loop (Griffith et al., 1999). A complex of proteins that binds the telomere, called the
shelterin complex, helps facilitate this t-loop and also helps “shelter” the telomere from
the DNA damage response. The shelterin complex consists of telomere binding proteins, the telomere repeat binding factors 1 (TRF1) and 2 (TRF2), and the single-stranded telomere binding protein, protection of telomeres 1 (POT1). The proteins TRF1- interacting nuclear factor 2 (TIN2), tripeptidyl peptidase 1 (TPP1) and Ras-proximate protein 1 (RAP1) facilitate the telomere-binding protein interactions in the complex (Figure 1) (de Lange, 2005). Proteins involved in DNA repair and DNA damage signaling also associate with the telomere but are unable to trigger the DNA damage response or cell cycle arrest (Matulić et al., 2007; Zhu et al., 2000).
2
Figure 1: T-loop with shelterin complex.
Shelterin proteins facilitate looping of the telomere DNA (t-loop). DNA and proteins to the right of the // represent the telomeric region.
The telomere is essential for protecting genomic DNA from deteriorating during the life-cycle of the cell. With each cell division, the DNA replication machinery cannot fully replicate the very end of the telomere; this is known as the “end replication problem”. There is a steady loss of 50-150 base-pairs of DNA per cell division. (Makarov et al., 1997; Sfeir and de Lange, 2012). Eventually, when a cell has undergone numerous
cell divisions, the telomere becomes “critically short”. Consequently, the telomere can no
longer perform its function; shelterin proteins can no longer bind; senescence is induced. If genetic or epigenetic changes occur such that cell-cycle checkpoint proteins are altered in a cell, the cell will continue to proliferate even with this extreme telomere dysfunction.
3
When the telomere reaches about 1.5 kilobases in length, “crisis” occurs, in which cytogenetic abnormalities or cell death ensue (Counter et al., 1992; Greenberg, 2005; Hemann et al., 2001; Kim et al., 1994). The chromosome instability that occurs at “crisis” triggers neoplastic transformation in surviving cells (Greenberg, 2005). This presents cells with a problem due to the need for unlimited proliferative capacity. Cancer cells bypass this problem by activating a telomere maintenance mechanism (TMM) that returns chromosome stability and allows continued proliferation.
I.2 Telomerase
Most cancer tumor types express the enzyme telomerase to allow for continued proliferation. It is composed of two subunits: the reverse transcriptase subunit of telomerase performs de novo synthesis of telomere repeats; the associated RNA molecule, TERC, acts as a template so that the reverse transcriptase can add the repeats to the end of the chromosome (Greider and Blackburn, 1985; Morin, 1989). The proliferative capacity that telomerase provides is not only important for cancer cells but also stem cells. Stem cells allow for tissue regeneration and require telomerase expression to prevent telomere shortening and therefore dysfunction, senescence and/or apoptosis (Batista, 2014). Limited telomerase activity in an adult organism cannot compensate for continued telomere shortening over a lifetime and explains the link between telomeres, telomerase and aging (Collins and Mitchell, 2002).
I.3 Alternative lengthening of telomeres
A minority of cancers use the recombination-based TMM of ALT for continual proliferation. Most of the cancer types that utilize ALT are of mesenchymal origin
4including osteosarcomas, soft-tissue sarcomas and the adult brain cancer glioblastoma multiforme. Among the most common cancer types such as breast carcinomas, ALT rarely plays a role (Bryan et al., 1997; Ferrandon et al., 2013; Hakin-Smith et al., 2003; Henson et al., 2005; Lafferty-Whyte et al., 2009; Subhawong et al., 2009;). Rare tumors express both telomerase and ALT in the same tumor (Gocha et al., 2013). Telomerasepositive tumors are capable of switching TMM to ALT when treated with telomerase inhibitors (Hu et al., 2012). These studies indicate that the need for ALT therapies may expand beyond that of ALT-positive tumors alone (Gocha et al., 2013; Hu et al., 2012).
One type of recombination that occurs in ALT cancer cells is homologous
recombination (HR)-dependent DNA replication telomere copying (Dunham et al.,
2000). A second type of recombination occurs as post-replicative exchanges between sister chromatids. A longer telomere on a sister chromatid can exchange a portion of its sequence with a shorter telomere on a sister chromatid to yield a net gain in length on the shorter sister chromatid. Intertelomeric exchanges could also take place between nearby homologous chromosomes (Conomos et al., 2014; Londoño-Vallejo et al., 2004). A third
type of recombination is termed HR-mediated t-loop junction resolution. The t-loop
conformation of the telomere may allow for intratelomeric recombination and resolution of the t-loop. A circular extrachromosomal telomere repeat substrate, called a t-circle, is produced from this type of recombination and can be used for rolling circle amplification (RCA) to rapidly add on to critically short telomeres. This may contribute to the heterogeneous lengths of telomeres in ALT cells (Cesare and Griffith, 2004; Henson et
al., 2009).
5
ALT cancer cells have distinct phenotypes that can be exploited to study proteins that affect ALT (Figure 2). ALT cancer cells have heterogeneous telomere lengths ranging from short telomeres, 2 kb in length, to long telomeres, up to 50 kb in length (Figure 2A). The long telomeres found in ALT cells are much longer than telomere lengths observed in telomerase-positive cells, which are approximately 10 kb in length (Bryan et al., 1995; Park et al., 1998). Another phenotype is the presence of ALT- associated promyelocytic leukemia protein (PML) bodies (APBs), a nuclear body shown by fluorescence in situ hybridization (FISH)/immunofluorescence (IF) studies to contain telomeric DNA, shelterin proteins, DNA repair proteins and PML (Yeager et al., 1999) (Figure 2B). An elevated number of telomere sister chromatid exchanges (T-SCEs), as compared to telomerase-positive cells and the numbers of SCEs found elsewhere in the genome, can also be observed in ALT cells (Betcher et al., 2004; Londono-Vallejo et al., 2004) (Figure 2C). A unique assay detects T-SCEs and is termed chromosomeorientation FISH (CO-FISH) in which G- and C-strands of DNA at the telomere are uniquely labeled to detect the exchange between sister chromatids (Bailey et al., 1996; Bailey et al., 2004; Goodwin and Meyne, 1993). ALT cells also have an abundance of linear and circular single-stranded or double-stranded extrachromosomal telomere repeat (ECTR) DNA, (telomeric DNA that has been detached from the chromosome), as compared to telomerase-positive cells (Nabetani and Ishikawa, 2009) (Figure 2D).